Chin Kim

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

Tae Won Kim, J. Roh, H. Chung, 2012, Investigational New Drugs.

Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator-activated Receptor-γ Agonist, in Healthy Subjects.

M. Park, C. Kim, Chin Kim, 2015, Clinical therapeutics.

Effect of ketoconazole on lobeglitazone pharmacokinetics in Korean volunteers.

M. Park, Youn Nam Kim, Jangik I. Lee, 2014, Clinical therapeutics.